Lexicon Pharmaceuticals, Inc. LXRX
1.80
(0.06)
(3.23%)
as of 25 Sep
- Market cap
- $854.3M
- P/E
- 0.0×
Follow LXRX
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.40 | 0.00 | 0.00 | 0.00 |
P/S ratio |
8.38 | 7.62 | 292.02 | 2,372.72 | 1,925.73 | 15.80 | 1.37 | 11.12 | 11.62 | 18.61 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.88 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
(24.23) | (11.02) | (6.96) | (15.29) | (25.14) | (11.07) | (18.09) | (25.90) | (31.59) | (30.23) |
P/B ratio |
3.88 | 1.62 | 3.78 | 2.82 | 5.05 | 2.42 | 3.76 | 0.00 | 15.60 | 9.37 |
Price to Tangible BV |
6.63 | 2.34 | 7.24 | 4.54 | 8.31 | 3.39 | 8.34 | 0.00 | 0.00 | 24.79 |
EV/Sales |
7.54 | 3.23 | 234.53 | 1,736.13 | 1,642.30 | 9.96 | 1.29 | 12.46 | 10.91 | 15.52 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.83 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(5.53) | (0.56) | (1.74) | (2.72) | (5.62) | (1.67) | 3.64 | (5.30) | (5.39) | (7.00) |
EV/FCF |
(5.45) | (0.56) | (1.74) | (2.68) | (5.55) | (1.81) | 3.64 | (5.30) | (5.39) | (6.99) |
Quick Ratio |
4.73 | 5.34 | 5.42 | 5.97 | 3.92 | 3.26 | 5.02 | 4.52 | 2.99 | 2.15 |
Current Ratio |
4.88 | 5.44 | 5.60 | 6.08 | 4.02 | 3.37 | 5.17 | 4.72 | 3.05 | 2.17 |
Net Debt/EBITDA |
0.91 | 0.71 | 0.42 | 0.89 | 0.97 | 3.19 | (0.18) | (0.86) | 0.51 | 1.97 |
Debt/Assets |
29.19% | 33.61% | 43.37% | 25.67% | 1.66% | 6.01% | 58.70% | 86.23% | 56.28% | 21.33% |
Debt/Equity |
0.50 | 0.69 | 1.07 | 0.43 | 0.02 | 0.08 | 2.09 | (9.28) | 3.60 | 0.64 |
Asset Turnover |
0.21 | 0.12 | 0.01 | 0.00 | 0.00 | 0.08 | 0.92 | 0.18 | 0.20 | 0.14 |
Operating CF/Net income |
1.35 | 0.89 | 0.91 | 0.87 | 0.99 | 2.44 | 0.87 | 1.23 | 1.51 | 1.34 |
Capex/Depreciation |
0.00 | (0.43) | (0.20) | (1.14) | (3.53) | 2.77 | (0.01) | (0.02) | (0.06) | (0.09) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (39.72%) | (167.66%) | (168.50%) | (88.37%) | (65.01%) | (42.84%) | 286.97% | (575.96%) | (109.00%) | (59.31%) | |
| (20.83%) | (75.93%) | (83.60%) | (61.56%) | (51.52%) | (18.85%) | 37.08% | (33.45%) | (26.97%) | (23.31%) | |
ROIC |
(46.81%) | (1,485.93%) | (475.14%) | (219.91%) | (186.85%) | (182.69%) | 97.55% | (110.26%) | (2,594.22%) | 0.00% |
Return on Tangible Assets |
(60.73%) | (98.51%) | (120.50%) | (85.12%) | (129.11%) | (52.67%) | 45.43% | (79.08%) | (52.52%) | (61.82%) |
Average Days of Receivables |
17.47 | 40.79 | 306.19 | 73.53 | 17.15 | 6.01 | 64.07 | 34.21 | 19.21 | 34.50 |
Research and Development Expense of Revenue |
122.73% | 271.81% | 4,890.95% | 37,997.12% | 18,471.81% | 640.22% | 28.54% | 158.59% | 166.02% | 206.89% |
Selling, General and Administrative Expense of Revenue |
74.93% | 460.42% | 9,466.94% | 34,592.09% | 10,853.02% | 196.83% | 17.65% | 100.86% | 72.08% | 54.45% |
Intangible Assets out of Total Assets |
0.24 | 0.15 | 0.19 | 0.23 | 0.33 | 0.22 | 0.15 | 0.33 | 0.22 | 0.21 |
Share Based Compensation of Revenue |
25.13% | 43.43% | 1,191.03% | 8,287.77% | 3,549.33% | 55.32% | 4.41% | 18.50% | 10.33% | 9.40% |
Graham Net Nets |
0.06 | 0.40 | 0.11 | 0.19 | 0.11 | 0.29 | 0.08 | (0.20) | (0.04) | 0.03 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.50 | 2.54 | 0.00 | 0.00 |
Earnings Yield |
(12.17%) | (86.49%) | (50.31%) | (30.65%) | (15.48%) | (16.08%) | 29.40% | (17.32%) | (11.47%) | (8.98%) |
Free Cash Flow Yield |
(16.50%) | (75.93%) | (46.18%) | (27.34%) | (15.38%) | (34.83%) | 25.80% | (21.16%) | (17.43%) | (11.92%) |
Revenue per Share |
0.14 | 0.10 | 0.01 | 0.00 | 0.00 | 0.22 | 3.03 | 0.60 | 0.87 | 0.76 |
Operating CF per Share |
(0.19) | (0.56) | (0.73) | (0.54) | (0.60) | (1.29) | 1.07 | (1.40) | (1.76) | (1.69) |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.01) | (0.01) | 0.10 | 0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
(0.19) | (0.56) | (0.73) | (0.54) | (0.61) | (1.19) | 1.07 | (1.41) | (1.76) | (1.69) |
Cash per Share |
0.27 | 0.74 | 0.77 | 0.83 | 0.60 | 1.37 | 2.56 | 1.51 | 2.95 | 3.34 |
Shareholders Equity per Share |
0.30 | 0.46 | 0.42 | 0.71 | 0.78 | 1.41 | 1.10 | (0.25) | 0.65 | 1.52 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.30 | 0.46 | 0.42 | 0.71 | 0.78 | 1.41 | 1.10 | (0.25) | 0.65 | 1.52 |
Free Cash Flow |
(67.85) | (179.81) | (162.37) | (90.18) | (88.24) | (132.04) | 113.74 | (148.70) | (185.62) | (175.86) |
Working Capital |
81.03 | 200.95 | 145.00 | 117.69 | 66.80 | 110.91 | 272.41 | 136.57 | 216.51 | 193.23 |
Capital Expenditures |
— | (1.03) | (0.47) | (1.33) | (1.22) | 10.93 | (0.07) | (0.09) | (0.23) | (0.23) |
Net Current Asset Value |
24.45 | 93.72 | 40.23 | 63.69 | 65.61 | 110.30 | 37.14 | (137.22) | (46.28) | 39.65 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.93 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.03 | 0.39 | 9.54 | 4.10 | (0.46) | 0.00 | 0.00 | 0.00 | 0.00 |
Net Profit Margin |
(101.08%) | (644.78%) | (14,710.88%) | (73,341.01%) | (29,448.99%) | (244.11%) | 40.40% | (190.71%) | (134.14%) | (165.85%) |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.12 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
1.25 | 0.96 | 1.17 | 0.56 | 0.29 | 13.38 | 0.36 | 0.32 | 0.23 | 0.13 |
Cash ROIC |
(27.04%) | (37.44%) | (45.19%) | (29.78%) | (43.53%) | (44.64%) | 15.74% | (43.44%) | (32.51%) | (32.22%) |
Accounts Receivable Turnover |
17.01 | 13.87 | 2.32 | 6.62 | 1.46 | 0.84 | 10.31 | 11.76 | 14.89 | 18.86 |
Accounts Payable Turnover |
0.03 | 0.04 | 0.01 | 0.04 | 0.00 | 0.22 | 0.27 | 0.10 | 0.04 | 0.00 |
Inventory Turnover |
1.07 | 2.01 | 0.23 | 0.00 | — | 0.84 | 0.72 | 0.75 | 0.57 | — |
Average Days of Payables |
4,106.92 | 8,770.07 | 61,788.06 | 8,885.66 | 0.00 | 1,034.83 | 1,375.73 | 1,765.95 | 7,450.31 | 0.00 |
Days of Inventory on Hand |
374.32 | 136.88 | 1,636.06 | 0.00 | — | 65.28 | 479.32 | 685.75 | 374.42 | — |
Average Receivables |
2.93 | 2.24 | 0.52 | 0.02 | 0.20 | 28.46 | 31.23 | 5.37 | 6.16 | 4.20 |
Average Payables |
8.94 | 14.60 | 12.39 | 9.77 | 7.31 | 8.82 | 12.12 | 25.41 | 45.82 | 36.30 |
Average Inventory |
0.26 | 0.31 | 0.36 | — | — | 2.29 | 4.46 | 3.31 | 3.31 | — |
Average Assets |
241.70 | 263.92 | 211.86 | 165.60 | 170.35 | 310.75 | 350.93 | 360.34 | 456.08 | 563.79 |
Average Common Equity |
126.74 | 119.53 | 105.12 | 115.36 | 134.98 | 136.74 | 45.35 | 20.93 | 112.83 | 221.63 |
Columns are period end dates